Capricor Therapeutics Inc (NASDAQ: CAPR) – Suitable For Long Term Buy?
Currently, there are 45.58M common shares owned by the public and among those 40.12M shares have been available to trade. The company’s stock has a 5-day price change of -41.88% and -51.56% over the past three months. CAPR shares are trading -47.10% year to date (YTD), with the 12-month market performance up to 39.31% higher. […]
Growth Story Still Intact For Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Inc (CAPR) concluded trading on Thursday at a closing price of $14.36, with 3.31 million shares of worth about $47.6 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 182.68% during that period and on March 20, 2025 the price saw a […]
